[DISCLOSURE] Isu Abxis (086890) has signed a 1.9 billion won (US$1.6 million) with Iran’s Fara Teb Ayeen to supply a treatment for Gaucher's disease, it announced on June 20. This amounts to 17.14 percent of its recent revenue.